| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |